FDA Approved: DIAZEPAM — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved a supplemental application for diazepam submitted by Lupin Pharmaceuticals, Inc. The approval relates to changes under the approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome
• Anxiety Disorders
• Muscle Spasticity
• Seizure Disorders

Drugs mentioned

• Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)